Empire (AMEX:EFH)
Historical Stock Chart
From May 2019 to May 2024
CSMG Technologies, Inc., (OTCBB: CTUM), a technology management company
focused on commercializing human live tissue surgical bonding devices,
announced updating its investment banking firm, Empire Financial Group
(Amex: EFH), at Empire’s annual Key Producers
Meeting one year after EFH was retained, and was successful in funding
the Company.
CSMG President and CEO Donald S. Robbins informed the representatives of
Empire that in the past year since Empire started funding CSMG to
commercialize CSMG’s tissue welding
technology. We have attained a number of important, key accomplishments
during the last 12 months, among them:
Hired Frank D'Amelio, an internationally recognized medical device
expert, to lead the commercialization of our patented surgical device
for bonding live human tissue.
Hired Stellartech, a leading surgical device design company, to design
and manufacture the LTC commercial electro-surgery generator, and ViR
and Ventrex, leading instrument designers and manufacturers, to design
and manufacture the disposable instruments.
Retained a major U.S. University to complete important laboratory work
Completed the duct and vessel sealing procedure equipment for FDA
filing
Retained a leading Washington, DC law firm specializing in FDA filings
Filed a 510(K) submission with the U.S. FDA for the duct and vessel
sealer and two instruments.
Identified 13 surgical specific procedure license and distribution
opportunities, and of these have formed 5 surgical procedure specific
subsidiaries under subsidiary Live Tissue Connect (LTC)
Nearly completed end-to-end anastomosis prototype and testing in
Ukraine
Engaged an international research firm to audit Ukraine human surgeries
Currently preparing documentation for Europe’s
CE Mark certification
Added two key surgeons to the U.S. advisory group to provide surgeon
training and surgical feedback
Have 29 surgeons, engineers and scientists working on the LTC project
in Ukraine
Have five engineers in the United States working on product
commercialization
Had European Union, Ukraine, and Canadian patents issued, which
supplement the exiting U.S. and Australian patents already issued
Mr. Robbins also informed the Empire representatives that CSMG had 40 US
and international issued or pending.
"We have enjoyed working with Empire Financial Group, as they understand
our technologies, and importantly, have a successful track record
raising capital. Over this last 12 month period CSMG’s
market cap has grown from $8.25 million to about $26.4 million, while we
reduced debt by approximately $400 thousand," added Mr. Robbins.
Mr. Ed Cabrera, Senior Managing Director of Investment Banking, Empire
Financial Group said, "We are proud of our association with CSMG, and
continue to believe that it owns a truly disruptive technology that has
the potential to alter surgical procedures."
About Empire Financial Group, Inc.
Empire Financial Group and its subsidiaries provide investment banking
and corporate financing services, as well as securities brokerage, asset
management, and market making services in the United States, Europe and
Asia. It provides brokerage services directly to retail customers, and
small- to mid-sized institutions. Empire Investment Advisors provides
investment advisory services to its customers, independent registered
investment advisors, and unaffiliated broker dealers. Empire Financial
Holding also offers ancillary services, including market data and
financial information, portfolio tracking and records management, cash
management services, and account security. Based in Longwood, Florida,
the company, founded in 2000, has offices in NYC, NY and other locations
throughout the U.S.
About CSMG Technologies, Inc.
CSMG Technologies is a technology management company that finances,
owns, develops, licenses and markets innovative advanced technologies
and business opportunities created in the Ukraine through a network of
scientific institutes and private organizations. CSMG is focused on two
primary subsidiaries, Live Tissue Connect, Inc. and landfill gas
processing.
Information regarding procedures using the technology and technical
information regarding the technology will be removed from our web site
pending FDA clearance. For further information on CSMG Technologies and
its various subsidiaries, please visit our website at www.ctum.com.
Sign up to receive CSMG Technologies automated email press releases and
other notifications: Please go to http://www.ctum.com/contact_information.html
and fill-in information.
This press release may contain forward-looking information within the
meaning of Section 21E of the Securities Exchange Act of 1934 as amended
(the Exchange Act), including all statements that are not statements of
historical fact regarding the intent, belief or current expectations of
the company, its directors or its officers with respect to, among other
things: (i) the company's financing plans; (ii) trends affecting the
company's financial condition or results of operations; (iii) the
company's growth strategy and operating strategy; and (iv) the
declaration and payment of dividends. The words "may," "would," "will,"
"expect," "estimate," "anticipate," "believe," "intend" and similar
expressions and variations thereof are intended to identify
forward-looking statements. Investors are cautioned that any such
forward-looking statements are not guarantees of future performance and
involve risks and uncertainties, many of which are beyond the company's
ability to control, and that actual results may differ materially from
those projected in the forward-looking statements as a result of various
factors.